Integra LifeSciences Holdings Corporation (IART - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The upside was driven by the company’s announcement of better-than-expected earnings and revenues for the third quarter of 2016. This led to solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down nearly 3.4% in the past one-month time frame.
In the last 30 days, the company witnessed five positive estimate revisions and the Zacks Consensus Estimate also moved higher over the same time frame, suggesting that more solid trading could be ahead for Integra. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Integra currently has a Zacks Rank #3 (Hold).
INTEGRA LIFESCI Price
A better-ranked stock in the Med-Biomed/Gene industry is Anika Therapeutics Inc. (ANIK - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here
Is IART going up? Or down? Predict to see what others think: Up or Down
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Integra LifeSciences Holdings Corporation (IART - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The upside was driven by the company’s announcement of better-than-expected earnings and revenues for the third quarter of 2016. This led to solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down nearly 3.4% in the past one-month time frame.
In the last 30 days, the company witnessed five positive estimate revisions and the Zacks Consensus Estimate also moved higher over the same time frame, suggesting that more solid trading could be ahead for Integra. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Integra currently has a Zacks Rank #3 (Hold).
INTEGRA LIFESCI Price
A better-ranked stock in the Med-Biomed/Gene industry is Anika Therapeutics Inc. (ANIK - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here
Is IART going up? Or down? Predict to see what others think: Up or Down
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on IART - FREE
Get the latest research report on ANIK - FREE